Foghorn Therapeutics Inc (FHTX) — Cash Flow Reinvestment Rate
Foghorn Therapeutics Inc (FHTX) has a Cash Flow Reinvestment Rate of 0.59x as of March 2022, reinvesting $159.41 Million (capex $247.00K plus investments $-159.16 Million) from operating cash flow of $271.53 Million. Explore FHTX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Foghorn Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Foghorn Therapeutics Inc across 1 annual periods. Also explore how large is Foghorn Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Foghorn Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Foghorn Therapeutics Inc. For live market cap and broader valuation context, see Foghorn Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.26x | $244.32 Million | $193.61 Million | $1.21 Million | — |